426 results on '"Chen, Miao‐Fen"'
Search Results
2. Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins
3. Spheroids Generated from Malignant Pleural Effusion as a Tool to Predict the Response of Non-Small Cell Lung Cancer to Treatment
4. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma
5. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer
6. The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling
7. A meta‐analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
8. A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy
9. SO020 / #204 - COMPARISON OF TASTE FUNCTION IN HEAD AND NECK CANCER PATIENTS RECEIVING INTENSITY-MODULATED PROTON THERAPY (IMPT) VERSUS INTENSITY-MODULATED RADIOTHERAPY (IMRT)
10. The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma
11. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling
12. Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer
13. Supplementary Figure 2 from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
14. Supplementary Figure 3 from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
15. Supplementary Figure 4 from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
16. Data from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
17. Supplementary methods and legends from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
18. Supplementary Figure 1 from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
19. Supplementary Figure 5 from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
20. Supplementary Figure 6 from 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
21. Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma
22. Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma
23. The relationship of nutritional status with anticancer immunity and its prognostic value for head and neck cancer.
24. Risk of critical limb ischemia in long-term uterine cancer survivors: A population-based study
25. Taste Function in Patients With Head and Neck Cancer Receiving Intensity-Modulated Radiotherapy—Reply
26. Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
27. Perioperative Complications and Oncologic Outcomes after Radical Cystectomy in End-Stage Renal Disease Patients with Bladder Cancer Obtained Using a Standardized Reporting System
28. Prospective Evaluation of Taste Function in Patients With Head and Neck Cancer Receiving Intensity-Modulated Radiotherapy
29. Estimation of life expectancy and quality-adjusted life expectancy in non-metastatic nasopharyngeal cancer patients treated by intensity-modulated radiotherapy with or without chemotherapy
30. Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment
31. TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer
32. Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma
33. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma
34. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: Correlations with parotid dose and quality of life
35. Inflammation‐induced myeloid‐derived suppressor cells associated with squamous cell carcinoma of the head and neck
36. Role of Interleukin-6 in the Radiation Response of Liver Tumors
37. Clinical outcome in lung cancer with a second malignancy: The time sequence matters
38. Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells
39. TGF-β1 mediates the radiation response of prostate cancer
40. Detection of Mucosal Recurrent Nasopharyngeal Carcinomas After Radiotherapy With Narrow-Band Imaging Endoscopy
41. Streptococcus mutans promotes tumor progression in oral squamous cell carcinoma
42. The Risk of Peripheral Arterial Disease in Long-Term Uterine Cancer Survivors: A Population-BasedStudy
43. Treatment Strategy for Dialysis Patient with Urothelial Carcinoma
44. Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers
45. Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression
46. Role of Peroxiredoxin I in Rectal Cancer and Related to p53 Status
47. Significance of Interleukin-6 Signaling in the Resistance of Pharyngeal Cancer to Irradiation and the Epidermal Growth Factor Receptor Inhibitor
48. Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma
49. Lung cancer outcome in the setting of chronic kidney disease: Does the glomerular filtration estimation formula matter?
50. Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.